- STAT+: Pharmalittle: We’re reading about Roche accusing U.S. of ‘blackmail,’ a ruling on skinny labels, and moreDrugmakers and patient groups asked the FDA to pause former commissioner Marty Markary's National Priority Voucher drug review programSTAT · 1mo ago↗ source
- Pharma is betting big on PD-1/VEGF bispecifics. But are companies chasing the wrong target?<figure><div><img src="https://imgproxy.divecdn.com/xbHcBuJpB2jn4XdBnacn9EL1qH4IPhhgp3V92WERlvI/g:ce/rs:fill:1600:900:1/Z3M6Ly9kaXZlc2l0ZS1zdG9yYWdlL2RpdmVpbWFnZS9TY3JlZW5zaG90XzIwMjYtMDYtMDNfYXRfM…BioPharma Dive · 1mo ago↗ source
- Opinion: How living and practicing medicine abroad complicated my beliefs about universal health care systems“I believe deeply in universal health care. But universal care must also mean universal safety and accountability, not merely universal access.”